Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis.

PLoS One · 2022 · PMC9122181 · PMID 35594278

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

The results revealed that whether SBRT followed by TACE or TACE followed by SBRT, SBRT plus TACE was significantly better than monotherapy for 1- and 2- year survival rates of patients; however, compared with patients receiving TACE followed by SBRT, there was a nonsignificant trend for patients receiving SBRT followed by TACE to have a higher ORR than monotherapy.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.